marijuana stocks news

 

United Cannabis Corporation (CNAB)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 89   95   91   –  
Cost of Revenue 27 5 2
Gross Profit 62   91   89   –  
Operating Expenses
Research Development 0 12 95 76
Selling General and Administrative 559 770 543 419
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (497) (691) (548) (495)
Income from Continuing Operations
Total Other Income/Expenses Net (769) (373) (91) 0
Earnings Before Interest And Taxes (1,316) (1,065) (639) (495)
Interest Expense 20 64 67
Income Before Tax (1,336) (1,129) (707) (495)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,336) (1,129) (707) (495)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,336) (1,129) (707) (495)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,336) (1,129) (707) (495)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GrowGeneration Corp. (GRWG) Appoints Becky Gebhardt as SVP Marketing and E-commerce

GrowGeneration Appoints Becky Gebhardt as SVP Marketing and E-commerce GrowGeneration Corp. (NASDAQ:…

TerrAscend Corp. (TRSSF) Announces Closing of US$45.5 Million Non-Brokered Debt Financing

TerrAscend Announces Closing of US$45.5 Million Non-Brokered Debt Financing TerrAscend Corp. (“TerrAscend”…

The Supreme Cannabis Company, Inc. (SPRWF) Signs LOI with Malta Enterprises for Cannabis License

Supreme Cannabis Signs LOI with Malta Enterprises for Cannabis License The Supreme…

AbbVie Inc. (ABBV) to Present Extensive Data from its Migraine Portfolio at the 2022 American Headache Society®

AbbVie to Present Extensive Data from its Migraine Portfolio at the 2022…